India city Hyderabad covid-19 vaccine medicines India city Hyderabad

Hyderabad pharma company's COVID-19 vaccine enters Phase I/II trial

Reading now: 387
www.livemint.com

COVID-19 subunit vaccine candidate in India following approval from the Drugs Controller General of India (DGCI). The vaccine candidate includes an antigen, in-licensed from BCM Ventures, Baylor College of Medicine's integrated commercialization team, along with Dynavax's advanced adjuvant CpG 1018.The announcement was made jointly by Biological E.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA